SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-13-201834
Filing Date
2013-05-06
Accepted
2013-05-06 17:01:14
Documents
12
Period of Report
2013-03-31
Filing Date Changed
2013-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d517784d10q.htm 10-Q 428053
2 EX-10.1 d517784dex101.htm EX-10.1 76482
3 EX-10.2 d517784dex102.htm EX-10.2 11809
4 EX-31.1 d517784dex311.htm EX-31.1 9403
5 EX-31.2 d517784dex312.htm EX-31.2 9423
6 EX-32.1 d517784dex321.htm EX-32.1 5419
  Complete submission text file 0001193125-13-201834.txt   3847449

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sgnt-20130331.xml EX-101.INS 516801
8 XBRL TAXONOMY EXTENSION SCHEMA sgnt-20130331.xsd EX-101.SCH 35044
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sgnt-20130331_cal.xml EX-101.CAL 61764
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sgnt-20130331_def.xml EX-101.DEF 231971
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgnt-20130331_lab.xml EX-101.LAB 272663
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgnt-20130331_pre.xml EX-101.PRE 276008
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35144 | Film No.: 13816863
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1